Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01911091 · ClinicalTrials.gov registry record · NA

Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)

A NA study of Obesity and Metabolic Disorder, sponsored by AdventHealth Translational Research Institute.

Active
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT01911091: Active NA study of Obesity and Metabolic Disorder, sponsored by AdventHealth Translational Research Institute.

NCT01911091 is a NA study of Obesity and Metabolic Disorder that is active but no longer recruiting, run by AdventHealth Translational Research Institute. The registered enrollment target is 56 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01911091, a NA study of Obesity and Metabolic Disorder, is active but no longer recruiting, sponsored by AdventHealth Translational Research Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect data to help researchers identify factors, such as certain proteins or genetic codes, that are secreted from muscle that are associated with the beneficial effects of exercise.

Primary Outcome

The difference will be measured in obese, lean and athletic participants. The Phosphocreatine (PCr) recovery time constant and the PCr level in oxygenated muscle at rest will be used to calculate maximum mitochondrial capacity.

Interventions

  • BEHAVIORAL Exercise

Study Locations (1)

Florida

  • Translational Research Institute for Metabolism and Diabetes - Orlando

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2013-07
Est. Completion 2025-12
Phase NA

What the registry record for NCT01911091 still lists

NCT01911091 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.

NCT01911091 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT01911091 about?

NCT01911091 is a clinical study titled "Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)". The purpose of this study is to collect data to help researchers identify factors, such as certain proteins or genetic codes, that are secreted from muscle that are associated with the beneficial effects of exercise.

What is the current status of trial NCT01911091?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2013-07. Estimated completion is 2025-12.

What conditions does trial NCT01911091 study?

This clinical trial studies the following conditions: Obesity, Metabolic Disorder, Lipid Metabolism Disorders, Disorder of Lipid Storage and Metabolism.

What interventions are being tested in trial NCT01911091?

The interventions under investigation include: Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01911091?

This trial is sponsored by AdventHealth Translational Research Institute, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01911091 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01911091's enrollment target sits among peer trials

56 689th of 1053 higher than 360 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02287428 · 56 participants · Phase 1

    Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

  • NCT02923011 · 56 participants · Phase 3

    Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas

  • NCT02935283 · 56 participants

    Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

  • NCT03375866 · 56 participants · NA

    Effects of Mixed Nut Consumption on Satiety and Weight Management

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01911091, the US trial registry maintained by the National Library of Medicine. NCT01911091 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.